Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
- 5 November 2005
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 115 (1), 168-177
- https://doi.org/10.1016/s0022-5223(98)70455-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Regional Angiogenesis Induced in Nonischemic Tissue by an Adenoviral Vector Expressing Vascular Endothelial Growth FactorHuman Gene Therapy, 1997
- Circumvention of Anti-Adenovirus Neutralizing Immunity by Administration of an Adenoviral Vector of an Alternate SerotypeHuman Gene Therapy, 1997
- VEGF Improves Myocardial Blood Flow but Produces EDRF-Mediated Hypotension in Porcine HeartsJournal of Surgical Research, 1996
- Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac PerformanceJournal of Cardiovascular Pharmacology, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.JCI Insight, 1994
- Growth factors: Regulation of normal and neoplastic growthThe Journal of Pathology, 1993
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjectsJournal of the American College of Cardiology, 1985